PL402028A1 - Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej - Google Patents

Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej

Info

Publication number
PL402028A1
PL402028A1 PL402028A PL40202812A PL402028A1 PL 402028 A1 PL402028 A1 PL 402028A1 PL 402028 A PL402028 A PL 402028A PL 40202812 A PL40202812 A PL 40202812A PL 402028 A1 PL402028 A1 PL 402028A1
Authority
PL
Poland
Prior art keywords
prasugrel
aliphatic
prasugrel hydrochloride
pharmaceutical grade
volume
Prior art date
Application number
PL402028A
Other languages
English (en)
Polish (pl)
Inventor
Marcin Cybulski
Wioleta Maruszak
Adam Formela
Kinga Trzcińska
Anna Witkowska
Magdalena Bodziachowska-Panfil
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL402028A priority Critical patent/PL402028A1/pl
Priority to PCT/PL2013/000164 priority patent/WO2014092589A1/en
Publication of PL402028A1 publication Critical patent/PL402028A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
PL402028A 2012-12-12 2012-12-12 Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej PL402028A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL402028A PL402028A1 (pl) 2012-12-12 2012-12-12 Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej
PCT/PL2013/000164 WO2014092589A1 (en) 2012-12-12 2013-12-12 Process for preparation of prasugrel hydrochloride polymorphic form b of pharmaceutical purity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL402028A PL402028A1 (pl) 2012-12-12 2012-12-12 Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej

Publications (1)

Publication Number Publication Date
PL402028A1 true PL402028A1 (pl) 2014-06-23

Family

ID=49958649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL402028A PL402028A1 (pl) 2012-12-12 2012-12-12 Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej

Country Status (2)

Country Link
PL (1) PL402028A1 (xx)
WO (1) WO2014092589A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105669696B (zh) * 2014-11-21 2019-03-26 四川海思科制药有限公司 一种盐酸普拉格雷化合物
CN112898359A (zh) * 2019-12-03 2021-06-04 晨光生物科技集团股份有限公司 一种低溶残晶体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004461A1 (fr) 2000-07-06 2002-01-17 Sankyo Company, Limited Sels d'addition acides de dérivés hydropyridine
TWI392681B (zh) 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法
ES2335369T3 (es) 2006-06-27 2010-03-25 Sandoz Ag Nuevo metodo para la preparacion de sales.
US20100261908A1 (en) 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
WO2010070677A2 (en) 2008-12-15 2010-06-24 Glenmark Generics Limited A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
CZ2009828A3 (cs) 2009-12-09 2011-06-22 Zentiva, K.S. Zpusob prípravy hydrochloridu 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu (prasugrelu hydrochloridu) v polymorfní forme B
US20130053569A1 (en) 2010-03-23 2013-02-28 Jayaraman Venkat Raman Process for the preparation of prasugrel hcl salt
WO2012018791A2 (en) * 2010-08-06 2012-02-09 Dr. Reddy's Laboratories Ltd. Preparation of prasugrel hydrochloride

Also Published As

Publication number Publication date
WO2014092589A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
MD20140084A2 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
NZ599342A (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
IN2014CN00473A (xx)
IN2014MN02106A (xx)
DE602008005461D1 (de) Verfahren zur herstellung von essigsäure-5-ä2-cyclopropyl-1-(2-fluorphenyl)-2-oxoethylü-4,5,6,7-tetrahydrothienoä3,2-cüpyridin-2-yl-ester (prasugrel)
MY167395A (en) Method for producing glufosinate p free acid
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
DK2091948T3 (da) Nye inhibitorer af glutaminylcyclase
EA201591545A1 (ru) C-3 алкил- и алкенил-модифицированные производные бетулиновой кислоты
PH12016500249A1 (en) Diazacarbazole derivatives as tau-pet-ligands
IN2013MU02828A (xx)
WO2014108919A3 (en) NOVEL INTERMEDIATE AND POLYMORPHS OF 1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-c] PYRIDINE-3-CARBOXAMIDE AND PROCESS THEREOF
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
UA105425C2 (ru) Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения
MX2015001023A (es) Proceso para preparacion de derivados de acido pirazol carboxilico.
TW201613931A (en) Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof
NZ603828A (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
MX2016003422A (es) Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen.
IN2014MN02467A (xx)
PL402028A1 (pl) Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej
WO2013128419A3 (en) Pharmaceutical compositions comprising boronic acid compounds
EA201290481A1 (ru) Способ получения гидрохлорида прасугреля в полиморфной форме в
NO20084217L (no) Fremgangsmate for fremstilling av polymorf form I av (S)-(+)-metyl-α-(2-klorfenyl)-6,7-dihydrotieno-[3,2-c]pyridin-5(4H)-acetathydrogensulfat
TW201612188A (en) The L-proline complex, monohydrate and crystal of a sodium-glucose contransporter 2 inhibitor
MX2015011505A (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.